Skip to main content
SpringerLink
Log in

Diabetes, Obesity, and the Metabolic Syndrome

  • Chapter
  • First Online:
Disease, Diagnoses, and Dollars

  • 357 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 19.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 27.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 27.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Association AD. Diabetes 4-1-1: Facts, Figures, and Statistics at a Glance. Atlanta: American Diabetes Association; 2006.

    Google Scholar 

  2. Health, United States, 2005. Atlanta: Centers for Disease Control and Prevention; 2005.

    Google Scholar 

  3. Herman WH, Sinnock P, Brenner E, et al. An epidemiologic model for diabetes mellitus: incidence, prevalence, and mortality. Diabetes Care. Jul–Aug 1984;7(4):367–371.

    Article  Google Scholar 

  4. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. Feb 7 2002;346(6): 393–403.

    Article  Google Scholar 

  5. Harris EL, Wagener DK, Dorman JS, Drash AL. Detection of genetic heterogeneity between families of insulin-dependent diabetes mellitus patients using linkage analysis. Am J Hum Genet. Jan 1985;37(1):102–113.

    Google Scholar 

  6. Polonsky KS. Dynamics of insulin secretion in obesity and diabetes. Int J Obes Relat Metab Disord. Jun 2000;24(Suppl 2):S29–S31.

    Google Scholar 

  7. de Luca C, Olefsky JM. Stressed out about obesity and insulin resistance. Nat Med. Jan 2006;12(1):41–42; discussion 42.

    Article  Google Scholar 

  8. Cavaghan MK, Ehrmann DA, Polonsky KS. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest. Aug 2000; 106(3):329–333.

    Article  Google Scholar 

  9. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. Jul 1997;20(7):1183–1197.

    Google Scholar 

  10. Genuth S, Alberti KG, Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. Nov 2003;26(11):3160–3167.

    Article  Google Scholar 

  11. Hanefeld M, Temelkova-Kurktschiev T, Schaper F, Henkel E, Siegert G, Koehler C. Impaired fasting glucose is not a risk factor for atherosclerosis. Diabet Med. Mar 1999;16(3):212–218.

    Article  Google Scholar 

  12. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. Feb 12 2001;161(3):397–405.

    Article  Google Scholar 

  13. Shaw JE, Zimmet PZ, Hodge AM, et al. Impaired fasting glucose: how low should it go? Diabetes Care. Jan 2000;23(1):34–39.

    Article  Google Scholar 

  14. Gabir MM, Hanson RL, Dabelea D, et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care. Aug 2000;23(8):1108–1112.

    Article  Google Scholar 

  15. Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, et al. Prevalence of hypertension in Hispanic and non-Hispanic white populations. Hypertension. Feb 2002;39(2):203–208.

    Article  Google Scholar 

  16. Kaplan RM, Morton D, Wingard DL, Barrett-Connor E. Should the threshold for fasting plasma glucose be reduced: The Rancho Bernardo Study. Unpublished manuscript. 2006.

    Google Scholar 

  17. Kanaya AM, Herrington D, Vittinghoff E, et al. Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease. Ann Intern Med. May 17 2005;142(10):813–820.

    Google Scholar 

  18. Buchanan TA, Xiang AH, Peters RK, et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes. Sep 2002;51(9):2796–2803.

    Article  Google Scholar 

  19. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. Jun 15 2002;359(9323):2072–2077.

    Article  Google Scholar 

  20. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. Apr 1997;20(4):537–544.

    Article  Google Scholar 

  21. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. May 3 2001;344(18):1343–1350.

    Article  Google Scholar 

  22. Kaplan RM, Ganiats TG, Sieber WJ, Anderson JP. The Quality of Well-Being Scale: critical similarities and differences with SF-36 [see comments]. Int J Qual Health C. 1998;10(6):509–520.

    Article  Google Scholar 

  23. Kaplan RM, Ganiats TG. Qalys – their ethical implications. JAMA. 1990;264(19): 2502–2503.

    Article  Google Scholar 

  24. Groessl EJ, Kaplan RM, Barrett-Connor E, Ganiats TG. Body mass index and quality of well-being in a community of older adults. Am J Prev Med. Feb 2004;26(2):126–129.

    Article  Google Scholar 

  25. Finkelstein EA, Fiebelkorn IC, Wang G. National medical spending attributable to overweight and obesity: how much, and who's paying? Health Aff (Millwood). Jan–Jun 2003;Suppl Web Exclusives:W3-219-226.

    Google Scholar 

  26. Finkelstein EA, Ruhm CJ, Kosa KM. Economic causes and consequences of obesity. Annu Rev Public Health. 2005;26:239–257.

    Article  Google Scholar 

  27. Allison DB, Fontaine KR, Manson JE, Stevens J, VanItallie TB. Annual deaths attributable to obesity in the United States. JAMA. Oct 27 1999;282(16):1530–1538.

    Article  Google Scholar 

  28. Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. Aug 24 2006;355(8): 763–778.

    Article  Google Scholar 

  29. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol. Jan 2006;21(1):1–6.

    Article  Google Scholar 

  30. Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. Nov 2005;28(11):2745–2749.

    Article  Google Scholar 

  31. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. Sep 2005;28(9):2289–2304.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. UCLA School of Public Health, Los Angeles, CA, USA

    Robert M. Kaplan Ph. D

Authors
  1. Robert M. Kaplan Ph. D
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Kaplan, R.M. (2009). Diabetes, Obesity, and the Metabolic Syndrome. In: Disease, Diagnoses, and Dollars. Springer, New York, NY. https://doi.org/10.1007/978-0-387-74045-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-74045-4_8

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-74044-7

  • Online ISBN: 978-0-387-74045-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation